-transparent.png){kind=logo}
A review is presented of antiglomerular basal membrane antibody-mediated glomerulonephritis (anti-GBM-Ab-nephritis) which constitutes 2-5% of all cases of acute glomerulonephritis. The disease frequently commences in the age group 20-30 years but may be encountered in all age groups, in women particularly at 60 years of age. The disease is due to autoantibodies (IgG) to the basal membranes in the glomeruli and alveoli. Deposition of IgG with C3 precipitates an inflammatory reaction which causes renal and possibly also pulmonary damage. It is possible to demonstrate anti-GMB-antibodies in the blood and, by means of immunofluorescence microscopy, these and C3 may be demonstrated in the basal membranes in the glomeruli and alveoli. The disease is still serious but introduction of immune-suppressive treatment and plasmapheresis has improved the prognosis considerably.
K Pagsberg, and
G Pedersen, and
F M Hansen
September 1979,
Medicine,
K Pagsberg, and
G Pedersen, and
F M Hansen
September 1982,
American journal of clinical pathology,
K Pagsberg, and
G Pedersen, and
F M Hansen
January 1999,
Nephron,
K Pagsberg, and
G Pedersen, and
F M Hansen
July 1979,
Clinical radiology,
K Pagsberg, and
G Pedersen, and
F M Hansen
April 1973,
Wisconsin medical journal,
K Pagsberg, and
G Pedersen, and
F M Hansen
November 1972,
Archives of environmental health,
K Pagsberg, and
G Pedersen, and
F M Hansen
April 2004,
Nephrology (Carlton, Vic.),
K Pagsberg, and
G Pedersen, and
F M Hansen
January 2020,
Academic pathology,
K Pagsberg, and
G Pedersen, and
F M Hansen
April 2001,
Scandinavian journal of urology and nephrology,
K Pagsberg, and
G Pedersen, and
F M Hansen
June 1983,
Kidney international,
